Cannabis and Hemp

Archived August 23, 2022

September 2021 Staff members from the IR-4 Project and industry experts provide an overview of hemp production, cultivation, pest management, and usage. https://www.youtube.com/watch?v=YpEDjuSv6iY

June 2021 SFIREG Presentation to the Tribal Pesticide Program Council (TPPC) for the purpose of supporting collaboration between Tribal Nations and States regarding Cannabis.

The Fall ACS virtual convention was held August 17 – August 20, 2020. In case you’re interested, there were many talks in the AGRO section including talks related to Hemp and pesticides. There was a presentation by EPA and also IR-4.

https://plan.core-apps.com/acs_sf20/abstract/a207f871-41b8-4b33-99d6-821614ca147e

AGRO 22: Hemp and federal pesticide registration

AGRO 23: Regulatory challenges associated with pesticide use and hemp production

AGRO 25: Addressing US growers’ drive for hemp agricultural chemicals

AGRO 26: IR-4 project’s efforts to facilitate crop protection products for hemp

AGRO 27: Crop protection in industrial hemp: The Canadian minor use experience

AGRO 30: Arthropod relationships with hemp and options for management in Virginia

AGRO 100: Postharvest fumigation with ozone to control brown marmorated stinkbug (Hempitera: Pentatomidae)

AGRO 240: Evaluation of biological insecticides to aid arthropod pest management in hemp

University of California’s publication on Herbicide Damage Symptoms and Hemp

Transcripts of Senate Hearings on Hemp:

Hemp: AAPCO letter to the U.S. Senate

AAPCO to FDA: Comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds

Colorado Department of Agriculture and Colorado Department of Public Health & Environment, Joint Letter to FDA: Comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds

Docket: FDA’s Request for Comments (due July 16, 2019): Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds: Public Hearing

Department of Health and Human Services June 7, 2019 Memo and Links to Webinars (you will need to copy and paste the links to the session you are interested in, and have adobe connect to view the webinar):

June 7, 2019

Dear Colleague:

On behalf of the U.S. Food and Drug Administration (FDA), the Office of External Affairs, Stakeholder Engagement Staff, thanks you for your participation at the FDA’s Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing held on Friday, May 31, 2019. Your participation was essential to enhance our awareness of the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.

Opening remarks by Norman E. “Ned” Sharpless MD, Acting Commissioner of Food and Drugs, are available at:https://www.fda.gov/news-events/speeches-fda-officials/remarks-dr-sharpless-fda-public-hearing-scientific-data-and-information-about-products-containing.

A recording of the entire hearing is available in four distinct segments. Each segment is in order based on the hearing’s agenda. Event materials are available at: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds.

Segment 1https://collaboration.fda.gov/pr8clhusaf72/(opening until morning break)
Segment 2https://collaboration.fda.gov/p69wh5mase6j/(after morning break until lunch)
Segment 3https://collaboration.fda.gov/plubcsivwhe6/(after lunch until afternoon break)
Segment 4https://collaboration.fda.gov/pihtiz8flmf7/(after afternoon break until closing)

We plan to publish the hearing transcript and slide decks in approximately 30 days athttps://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds.

Please remember to submit your comments and supporting data to the docket atFDA-2019-N-1482by 11:59 p.m. (ET), Tuesday, July 2, 2019.

Again, thank you for your interest related to products containing cannabis or cannabis-derived compounds and we look forward to your continued participation on this topic.

Sincerely,

Stakeholder Engagement Staff

Office of External Affairs

U.S. Food and Drug Administration